ACCESSION: MSBNK-SMB_Measured-HSA001P0324019
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.17, Processed 2025.02.17, Annotated 2025.03.05, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyoshu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 23
COMMENT: RAW_SPEC {'ProcedureBlank_10047': {'bp': 39363.0, 'sum': 185766.0}, '2_posi_10552': {'bp': 27328.0, 'sum': 119221.0}, '4_posi_10719': {'bp': 34129.0, 'sum': 124198.0}, '6_posi_10362': {'bp': 25331.0, 'sum': 113839.0}, '4_posi_10783': {'bp': 26267.0, 'sum': 126438.0}, '1_posi_10469': {'bp': 28118.0, 'sum': 145689.0}, '1_posi_10089': {'bp': 24518.0, 'sum': 123477.0}, 'BLK02_10407': {'bp': 29795.0, 'sum': 132872.0}, '2_posi_10110': {'bp': 30478.0, 'sum': 148872.0}, '1_posi_10212': {'bp': 31162.0, 'sum': 150969.0}, '6_posi_10489': {'bp': 22589.0, 'sum': 115045.0}, '4_posi_10027': {'bp': 32418.0, 'sum': 147872.0}, '3_posi_10614': {'bp': 27166.0, 'sum': 106064.0}, '14_posi_9960': {'bp': 26584.0, 'sum': 116095.0}, '6_posi_9629': {'bp': 27263.0, 'sum': 133885.0}, '2_posi_10678': {'bp': 33125.0, 'sum': 152904.0}, 'ProcedureBlank_10509': {'bp': 28758.0, 'sum': 129521.0}, '1_posi_10596': {'bp': 32354.0, 'sum': 151326.0}, 'BLK02_10214': {'bp': 31678.0, 'sum': 111872.0}, '3_posi_10091': {'bp': 29704.0, 'sum': 125700.0}, 'ProcedureBlank_9733': {'bp': 34647.0, 'sum': 178560.0}, 'ProcedureBlank_10365': {'bp': 33182.0, 'sum': 119155.0}, '14_posi_10719': {'bp': 30957.0, 'sum': 130368.0}}
COMMENT: RETENTION_TIME_STDEV 0.644
COMMENT: PRECURSOR_M/Z_RAW 324.216311
COMMENT: PRECURSOR_M/Z_STDEV 0.000101
COMMENT: PRECURSOR_IN_MS1 mz 324.216968; int 49.144; delta(ppm) 1.386625
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.102; C18H29NO4; [M+H]+; delta(ppm) 0.102101
COMMENT: PROPOSED_MF MS-FINDER 3.962; C18H29NO4; [M+H]+; delta(ppm) 0.099155
COMMENT: PROPOSED_MF MS-FINDER 2.627; C11H37N3OS3; [M+H]+; delta(ppm) -0.571396
COMMENT: PROPOSED_MF SIRIUS6_Sirius 9.862; C18H29NO4; [M+H]+; delta(ppm) 0.099155
COMMENT: PROPOSED_MF SIRIUS6_Sirius 9.653; C14H25N7O2; [M+H]+; delta(ppm) 8.381725
COMMENT: PROPOSED_MF SIRIUS6_Sirius 6.076; C12H30N5O3P; [M+H]+; delta(ppm) 3.287032
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.912; C13H30ClN5O2; [M+H]+; delta(ppm) -68920.173625
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.572; C15H30FNO5; [M+H]+; delta(ppm) -3.425183
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.534; C15H31O7; [M+H]+; delta(ppm) 8.365533
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.753; C11H29N7O2S; [M+H]+; delta(ppm) -2.016093
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.990; C16H27N4O3; [M+H]+; delta(ppm) 4.240423
COMMENT: PROPOSED_MF SIRIUS6_Sirius 2.000; C19H25N5; [M+H]+; delta(ppm) -4.025888
COMMENT: PROPOSED_MF SIRIUS6_Sirius 1.611; C7H25N13S; [M+H]+; delta(ppm) 6.266443
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C18H29NO4; [M+H]+; delta(ppm) 0.099155
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.698; RQTCBECAUUINSD-GXGMXFMGNA-N; [M+H]+; UNPD95697
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.620; JTRRPZVFSRBZIV-UHFFFAOYSA-N; [M+H]+; 5-{[(3-hydroxypropyl)amino]methyl}-10,14-dimethyl-2,7-dioxatetracyclo[8.4.0.0?,?.0?,?]tetradecan-6-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.597; JNDJPKHYZWRRIS-UHFFFAOYNA-N; [M+H]+; cicloprolol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.552; AKLNLVOZXMQGSI-UHFFFAOYNA-N; [M+H]+; bufetolol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.548; WGYOXLHUEHBVOF-UHFFFAOYSA-N; [M+H]+; 1-[4-(1-hydroxypropyl)-2-methoxyphenoxy]-3-(piperidin-1-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.519; AZDHNVVDNXRURH-UHFFFAOYSA-N; [M+H]+; 6-{[2-(dimethylazaniumyl)ethoxy]carbonyl}-2,3-dimethyl-5-(2-methylprop-1-en-1-yl)cyclohex-3-ene-1-carboxylate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.499; SHTWMNOBENSPNY-UHFFFAOYSA-N; [M+H]+; 3-{[(3-hydroxypropyl)amino]methyl}-8a-methyl-decahydro-2H-spiro[naphtho[2,3-b]furan-5,2'-oxiran]-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.476; MLVLRGDKFVUVPM-UHFFFAOYSA-N; [M+H]+; 2-{[2-(dimethylamino)ethoxy]carbonyl}-4-(4-methylpent-3-en-1-ylidene)cyclohexane-1-carboxylic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.465; PKMWXNTYYZTJQQ-UHFFFAOYSA-N; [M+H]+; 3-{[2-(dimethylamino)ethoxy]carbonyl}-8,8-dimethyl-1,2,3,4,5,6,7,8-octahydronaphthalene-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.465; SQDFUMNRZHDLGQ-UHFFFAOYSA-N; [M+H]+; 3-{[2-(dimethylazaniumyl)ethoxy]carbonyl}-5,5-dimethyl-1,2,3,4,5,6,7,8-octahydronaphthalene-2-carboxylate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.429; NLDRTHCIVHPBQA-OXMGLSMJNA-N; [M+H]+; UNPD92339
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.271; ZHMNKOPAHVBXQW-SYSZZGASNA-N; [M+H]+; Lycofawcine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.629; IBZYPBGPOGJMBF-VOTSOKGWNA-N; [M+H]+; N-Jasmonoylisoleucine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.368; SFLJQCLAPBTFNR-BPRAKBJFNA-N; [M+H]+; Brevisamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.316; LWJJYAYQOTXATC-IZZDOVSWSA-N; [M+H]+; 3-tigloyloxy-6-(2'-methylbutyryloxy)tropane
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.316; RNJWVOJSSZQWNZ-KPKJPENVSA-N; [M+H]+; 3-tigloyloxy-6-methylbutyryloxytropane
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.316; NUHKGPDBRUDFLM-PHYFOSRJNA-N; [M+H]+; UNPD186010
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.316; VOZGUTOOTJYSLX-NJCZDKFDNA-N; [M+H]+; UNPD177764
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.316; FFRMROQLCVKCCL-PUWZGUPBSA-N; [M+H]+; Bipolamide A
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.264; PPVFOZYARYOARE-UHFFFAOYSA-N; [M+H]+; guaiapate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.264; CZCNCPSVLLDKPE-UHFFFAOYSA-N; [M+H]+; 18-nitrooctadeca-9,12,15-trienoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.264; ZSFRGYXNXUCYAK-PDBXOOCHSA-N; [M+H]+; (9Z,12Z,15Z)-2-nitrooctadeca-9,12,15-trienoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.264; BDUIIOHQSYPXRT-UHFFFAOYSA-N; [M+H]+; 4-methyl-2-{2-[3-oxo-2-(pent-2-en-1-yl)cyclopentyl]acetamido}pentanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.264; MGGGOCSKDLGISA-UHFFFAOYSA-N; [M+H]+; 3-oxo-N-(2-oxooxolan-3-yl)tetradec-7-enamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.264; JKVULIFEVYXDTC-UHFFFAOYSA-N; [M+H]+; 4-({[(3-ethoxy-4-methoxyphenyl)methyl]amino}methyl)-2,2-dimethyloxan-4-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.264; MXAJYBDSRMKKOJ-UHFFFAOYSA-N; [M+H]+; N-{3,5a,9-trimethyl-2-oxo-dodecahydronaphtho[1,2-b]furan-8-yl}-2-methoxyacetamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.264; MICLDTZEBPLQFX-UHFFFAOYSA-N; [M+H]+; l-isoleucine, n-[[(1s,3as,6r,7as)-6-ethyl-2,3,3a,6,7,7a-hexahydro-1-hydroxy-1h-inden-4-yl]carbonyl]-
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.264; SVDGTPCLQKGRJP-UHFFFAOYSA-N; [M+H]+; 2-hydroxy-1-(3-hydroxy-2-methoxypyrrolidin-1-yl)-4,8-dimethylundeca-3,6,8-trien-1-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.264; VLKLZZGHWBZISX-UHFFFAOYSA-N; [M+H]+; 3,5-di-tert-butyl 2,4,6-trimethyl-1,4-dihydropyridine-3,5-dicarboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; JTRRPZVFSRBZIV-UHFFFAOYSA-N; [M+H]+; 5-{[(3-hydroxypropyl)amino]methyl}-10,14-dimethyl-2,7-dioxatetracyclo[8.4.0.0?,?.0?,?]tetradecan-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; SHTWMNOBENSPNY-UHFFFAOYSA-N; [M+H]+; 3-{[(3-hydroxypropyl)amino]methyl}-8a-methyl-decahydro-2H-spiro[naphtho[2,3-b]furan-5,2'-oxiran]-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.995; AKLNLVOZXMQGSI-UHFFFAOYNA-N; [M+H]+; bufetolol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.984; JNDJPKHYZWRRIS-UHFFFAOYNA-N; [M+H]+; cicloprolol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.979; RQTCBECAUUINSD-GXGMXFMGNA-N; [M+H]+; UNPD95697
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.979; AZDHNVVDNXRURH-UHFFFAOYSA-N; [M+H]+; 6-{[2-(dimethylazaniumyl)ethoxy]carbonyl}-2,3-dimethyl-5-(2-methylprop-1-en-1-yl)cyclohex-3-ene-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.979; MLVLRGDKFVUVPM-UHFFFAOYSA-N; [M+H]+; 2-{[2-(dimethylamino)ethoxy]carbonyl}-4-(4-methylpent-3-en-1-ylidene)cyclohexane-1-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.979; PKMWXNTYYZTJQQ-UHFFFAOYSA-N; [M+H]+; 3-{[2-(dimethylamino)ethoxy]carbonyl}-8,8-dimethyl-1,2,3,4,5,6,7,8-octahydronaphthalene-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.979; SQDFUMNRZHDLGQ-UHFFFAOYSA-N; [M+H]+; 3-{[2-(dimethylazaniumyl)ethoxy]carbonyl}-5,5-dimethyl-1,2,3,4,5,6,7,8-octahydronaphthalene-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; IBZYPBGPOGJMBF-VOTSOKGWNA-N; [M+H]+; N-Jasmonoylisoleucine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; SFLJQCLAPBTFNR-BPRAKBJFNA-N; [M+H]+; Brevisamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; ZHMNKOPAHVBXQW-SYSZZGASNA-N; [M+H]+; Lycofawcine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; PPVFOZYARYOARE-UHFFFAOYSA-N; [M+H]+; guaiapate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; LWJJYAYQOTXATC-IZZDOVSWSA-N; [M+H]+; 3-tigloyloxy-6-(2'-methylbutyryloxy)tropane
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; RNJWVOJSSZQWNZ-KPKJPENVSA-N; [M+H]+; 3-tigloyloxy-6-methylbutyryloxytropane
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; NLDRTHCIVHPBQA-OXMGLSMJNA-N; [M+H]+; UNPD92339
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; NUHKGPDBRUDFLM-PHYFOSRJNA-N; [M+H]+; UNPD186010
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; VOZGUTOOTJYSLX-NJCZDKFDNA-N; [M+H]+; UNPD177764
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; CZCNCPSVLLDKPE-UHFFFAOYSA-N; [M+H]+; 18-nitrooctadeca-9,12,15-trienoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; ZSFRGYXNXUCYAK-PDBXOOCHSA-N; [M+H]+; (9Z,12Z,15Z)-2-nitrooctadeca-9,12,15-trienoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; FFRMROQLCVKCCL-PUWZGUPBSA-N; [M+H]+; Bipolamide A
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; BDUIIOHQSYPXRT-UHFFFAOYSA-N; [M+H]+; 4-methyl-2-{2-[3-oxo-2-(pent-2-en-1-yl)cyclopentyl]acetamido}pentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; JKVULIFEVYXDTC-UHFFFAOYSA-N; [M+H]+; 4-({[(3-ethoxy-4-methoxyphenyl)methyl]amino}methyl)-2,2-dimethyloxan-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; MGGGOCSKDLGISA-UHFFFAOYSA-N; [M+H]+; 3-oxo-N-(2-oxooxolan-3-yl)tetradec-7-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; MICLDTZEBPLQFX-UHFFFAOYSA-N; [M+H]+; l-isoleucine, n-[[(1s,3as,6r,7as)-6-ethyl-2,3,3a,6,7,7a-hexahydro-1-hydroxy-1h-inden-4-yl]carbonyl]-
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; MXAJYBDSRMKKOJ-UHFFFAOYSA-N; [M+H]+; N-{3,5a,9-trimethyl-2-oxo-dodecahydronaphtho[1,2-b]furan-8-yl}-2-methoxyacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; SVDGTPCLQKGRJP-UHFFFAOYSA-N; [M+H]+; 2-hydroxy-1-(3-hydroxy-2-methoxypyrrolidin-1-yl)-4,8-dimethylundeca-3,6,8-trien-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; VLKLZZGHWBZISX-UHFFFAOYSA-N; [M+H]+; 3,5-di-tert-butyl 2,4,6-trimethyl-1,4-dihydropyridine-3,5-dicarboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; WGYOXLHUEHBVOF-UHFFFAOYSA-N; [M+H]+; 1-[4-(1-hydroxypropyl)-2-methoxyphenoxy]-3-(piperidin-1-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.492; AKLNLVOZXMQGSI-UHFFFAOYSA-N; [M+H]+; 1-(tert-butylamino)-3-[2-(oxolan-2-ylmethoxy)phenoxy]propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.056; JNDJPKHYZWRRIS-UHFFFAOYSA-N; [M+H]+; 1-[4-[2-(cyclopropylmethoxy)ethoxy]phenoxy]-3-(propan-2-ylamino)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.724; XFLILAJQDVNDTB-UHFFFAOYSA-N; [M+H]+; 1-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]-3-(propoxymethyl)phenyl]ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.500; CCMGNXCIXYOAOL-UHFFFAOYSA-N; [M+H]+; 1-[3-(ethoxymethyl)-4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]propan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.493; KFJRWDSGXLCBSG-UHFFFAOYSA-N; [M+H]+; 1-[4-[2-hydroxy-3-(propylamino)propoxy]-3-(propoxymethyl)phenyl]ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.493; CCOJZFVKVMICEM-UHFFFAOYSA-N; [M+H]+; 1-[2-[2-hydroxy-3-(propan-2-ylamino)propoxy]-5-(propoxymethyl)phenyl]ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.493; SJCMIKOLENLLHD-UHFFFAOYSA-N; [M+H]+; 1-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]-3-(propan-2-yloxymethyl)phenyl]ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.493; IEFBSRPZXVDVKT-UHFFFAOYSA-N; [M+H]+; 1-[4-[3-(tert-butylamino)-2-hydroxypropoxy]-3-(ethoxymethyl)phenyl]ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.474; JNLHPPFPJXHLKE-UHFFFAOYSA-N; [M+H]+; methyl 2-[2-hydroxy-3-(propan-2-ylamino)propoxy]-6-methyl-3-propan-2-ylbenzoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.467; AFZPMFFKUZAFPS-UHFFFAOYSA-N; [M+H]+; 2-(diethylamino)ethyl 2-butoxy-3-methoxybenzoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.467; GUKYZZSKXIILLI-UHFFFAOYSA-N; [M+H]+; 2-(butylamino)ethyl 2-butoxy-3-methoxybenzoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.467; SNFZSVZRZFZVIV-UHFFFAOYSA-N; [M+H]+; ethyl 2-[3-(dimethylamino)-2-hydroxypropoxy]-6-methyl-3-propan-2-ylbenzoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.286; CAAJQOXWAVAKRL-HMXJURRTSA-N; [M+H]+; 2-(dimethylamino)ethyl (2E)-2-[(6S)-6-acetyloxy-3,4,4a,5,6,7,8,8a-octahydro-1H-naphthalen-2-ylidene]acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.078; IBZYPBGPOGJMBF-QRHMYKSGSA-N; [M+H]+; (2S,3S)-3-methyl-2-[[2-[(1R,2R)-3-oxo-2-[(Z)-pent-2-enyl]cyclopentyl]acetyl]amino]pentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.647; PPVFOZYARYOARE-UHFFFAOYSA-N; [M+H]+; 1-[2-[2-[2-(2-methoxyphenoxy)ethoxy]ethoxy]ethyl]piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.500; RNPFYZLWVMKCHI-BUSXIPJBSA-N; [M+H]+; [(7S)-7-pentanoyloxy-5,6,7,8-tetrahydro-3H-pyrrolizin-1-yl]methyl pentanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.500; PIEVOKXIIFZVQL-UONOGXRCSA-N; [M+H]+; [(7S,8R)-7-(2,2-dimethylpropanoyloxy)-5,6,7,8-tetrahydro-3H-pyrrolizin-1-yl]methyl 2,2-dimethylpropanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.500; KCMGSZLKKRVNKG-UHFFFAOYSA-N; [M+H]+; ditert-butyl 4-prop-2-ynylpiperidine-1,4-dicarboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.500; XCYDUFDZEYUXTG-UHFFFAOYSA-N; [M+H]+; 3,5-dimethyl-7-[(2-methylpropan-2-yl)oxycarbonylamino]adamantane-1-carboxylic acid
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C18H30N1O4; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 20.706
MS$FOCUSED_ION: PRECURSOR_M/Z 324.216967
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-00di-0419000000-e8f60a17b17362384bd2
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  149.0235128 865.1654 149.023411 1.3823 97.99 0.4032 23 f{C8H5O3}/1.29ppm,p-C10H25N1O1
  205.0862594 304.1951 205.086122 2.1308 68.95 0.6375 22 f{C12H13O3}/1.65ppm,p-C6H17N1O1
  324.2496307 867.8689 324.249423 2.6831 91.72 1.0000 23 ?
  324.2877359 999.0000 324.287528 1.8687 41.60 0.6420 22 ?
PK$NUM_PEAK: 4
PK$PEAK: m/z int. rel.int.
  149.023513 865.17 865
  205.086259 304.20 304
  324.249631 867.87 867
  324.287736 999.00 999
//
